REFUSE TO PANIC

PROCRASTINATION USUALLY LEADS TO LOSSES

Cardiome Pharma (CRME) gets a "refusal to file" from FDA. I guess that explains its recent weakness. There might be potentially panic sell off this morning, which could be a buying opportunity. The question is whether to sell my current position first and looking to buy them back later. My thinking is that if the gap down is not significant, I would intend to sell my position and to see how it develops. If the gap is significant, I may hold my nose and stay put. Management remains confident and indicates that it will refile sooner rather than later. Looks like it gaps down quite a bit. I guess I have to hold it for now.